In the current study, we provide data demonstrating that IL-33/ST2 signalling is an essential step for HSC activation during experimental schistosomiasis, and disruptions in this pathway result in inappropriate granuloma organisation with altered extracellular matrix composition. This evidence concerns the gene IL33 and schistosomiasis.